市場調查報告書
商品編碼
1386270
神經生物標記物市場報告:2030 年趨勢、預測與競爭分析Neurological Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
神經生物標記的趨勢和預測
到 2030 年,全球神經生物標記市場預計將達到 147 億美元,2024 年至 2030 年年複合成長率為 11.7%。該市場的主要驅動力是液體活體組織切片的日益普及、人工智慧 (AI) 在神經生物標記開發中的使用增加以及個人化醫療需求的不斷成長。全球神經生物標記市場的未來充滿希望,醫院/醫院實驗室、獨立臨床診斷中心和研究機構市場都有機會。
神經生物標記市場洞察
Lucintel 預測,由於神經系統疾病的盛行率不斷增加,蛋白質體學將在預測期內達到最高成長。
在這個市場中,醫院和醫院實驗室將見證最高的成長,因為它們被認為是神經系統疾病診斷服務的主要提供者。
由於阿茲海默症、帕金森氏症和多發性硬化症等神經系統疾病的高盛行率,以及該地區醫療保健支出的增加,預計北美在預測期內仍將是最大的地區。
Neurological Biomarker Trends and Forecast
The future of the global neurological biomarker market looks promising with opportunities in the hospital & hospital laboratory, independent clinical diagnostic center, and research organizations markets. The global neurological biomarker market is expected to reach an estimated $14.7 billion by 2030 with a CAGR of 11.7% from 2024 to 2030. The major drivers for this market are growing adoption of liquid biopsy, increasing utilization of artificial intelligence (AI) in neurological biomarker development, and rising demand for personalized medicine.
A more than 150-page report is developed to help in your business decisions.
Neurological Biomarker by Segment
The study includes a forecast for the global neurological biomarker by type, application, end use, and region.
Neurological Biomarker Market by Type [Shipment Analysis by Value from 2018 to 2030]:
Neurological Biomarker Market by Application [Shipment Analysis by Value from 2018 to 2030]:
Neurological Biomarker Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
Neurological Biomarker Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Neurological Biomarker Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neurological biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neurological biomarker companies profiled in this report include-
Neurological Biomarker Market Insights
Lucintel forecasts that proteomic is expected to witness highest growth over the forecast period due to increasing prevalence of neurological diseases.
Within this market, hospitals and hospital laboratories will witness the highest growth as they are considered as a primary providers of diagnostic services for neurological disorders.
North America will remain the largest region over the forecast period due to high prevalence of neurological disorders, such as alzheimer's disease, parkinson's disease, and multiple sclerosis and rising healthcare expenditure in the region.
Features of the Global Neurological Biomarker Market
Market Size Estimates: Neurological biomarker market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Neurological biomarker market size by type, application, end use, and region in terms of value ($B).
Regional Analysis: Neurological biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the neurological biomarker market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neurological biomarker market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the neurological biomarker market size?
Answer: The global neurological biomarker market is expected to reach an estimated $14.7 billion by 2030.
Q.2 What is the growth forecast for neurological biomarker market?
Answer: The global neurological biomarker market is expected to grow with a CAGR of 11.7% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the neurological biomarker market?
Answer: The major drivers for this market are growing adoption of liquid biopsy, increasing utilization of artificial intelligence (AI) in neurological biomarker development, and rising demand for personalized medicine.
Q4. What are the major segments for neurological biomarker market?
Answer: The future of the neurological biomarker market looks promising with opportunities in the hospital & hospital laboratory, independent clinical diagnostic center, and research organizations markets.
Q5. Who are the key neurological biomarker market companies?
Answer: Some of the key neurological biomarker companies are as follows:
Q6. Which neurological biomarker market segment will be the largest in future?
Answer: Lucintel forecasts that proteomic is expected to witness highest growth over the forecast period due to increasing prevalence of neurological diseases.
Q7. In neurological biomarker market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to high prevalence of neurological disorders, such as alzheimer's disease, parkinson's disease, and multiple sclerosis and rising healthcare expenditure in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.